FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis

NYSE:FMS • US3580291066

23.47 USD
+0.01 (+0.04%)
At close: Mar 2, 2026
23.47 USD
0 (0%)
After Hours: 3/2/2026, 8:20:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall FMS gets a fundamental rating of 5 out of 10. We evaluated FMS against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of FMS while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on FMS.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FMS was profitable.
  • In the past year FMS had a positive cash flow from operations.
  • In the past 5 years FMS has always been profitable.
  • Each year in the past 5 years FMS had a positive operating cash flow.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • FMS has a better Return On Assets (3.16%) than 65.35% of its industry peers.
  • FMS has a Return On Equity of 7.35%. This is in the better half of the industry: FMS outperforms 65.35% of its industry peers.
  • FMS's Return On Invested Capital of 5.30% is in line compared to the rest of the industry. FMS outperforms 57.43% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FMS is significantly below the industry average of 9.12%.
  • The 3 year average ROIC (4.02%) for FMS is below the current ROIC(5.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • FMS's Profit Margin of 4.98% is fine compared to the rest of the industry. FMS outperforms 79.21% of its industry peers.
  • FMS's Profit Margin has declined in the last couple of years.
  • FMS's Operating Margin of 9.00% is fine compared to the rest of the industry. FMS outperforms 77.23% of its industry peers.
  • FMS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.62%, FMS is in line with its industry, outperforming 52.48% of the companies in the same industry.
  • FMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FMS is still creating some value.
  • The number of shares outstanding for FMS has been reduced compared to 1 year ago.
  • The number of shares outstanding for FMS has been reduced compared to 5 years ago.
  • FMS has a worse debt/assets ratio than last year.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that FMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of FMS (1.83) is comparable to the rest of the industry.
  • FMS has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FMS would need 6.19 years to pay back of all of its debts.
  • FMS has a Debt to FCF ratio of 6.19. This is comparable to the rest of the industry: FMS outperforms 56.44% of its industry peers.
  • FMS has a Debt/Equity ratio of 0.65. This is a neutral value indicating FMS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of FMS (0.65) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.83
ROIC/WACC1.01
WACC5.25%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FMS should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, FMS is in line with its industry, outperforming 49.51% of the companies in the same industry.
  • FMS has a Quick Ratio of 1.26. This is a bad value and indicates that FMS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.92, FMS is not doing good in the industry: 68.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • FMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.36%, which is quite good.
  • Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.15% on average per year.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.91% yearly.
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-1.52%

3.2 Future

  • Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.40% on average per year.
  • Based on estimates for the next years, FMS will show a small growth in Revenue. The Revenue will grow by 3.79% on average per year.
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.50, the valuation of FMS can be described as reasonable.
  • Based on the Price/Earnings ratio, FMS is valued cheaply inside the industry as 89.11% of the companies are valued more expensively.
  • FMS is valuated cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • FMS is valuated reasonably with a Price/Forward Earnings ratio of 9.84.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 90.10% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of FMS to the average of the S&P500 Index (28.11), we can say FMS is valued rather cheaply.
Industry RankSector Rank
PE 11.5
Fwd PE 9.84
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • FMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FMS is cheaper than 89.11% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 91.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.69
EV/EBITDA 6.11
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • FMS's earnings are expected to grow with 16.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y16.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • FMS has a Yearly Dividend Yield of 3.65%. Purely for dividend investing, there may be better candidates out there.
  • FMS's Dividend Yield is rather good when compared to the industry average which is at 0.48. FMS pays more dividend than 98.02% of the companies in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.65%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 4.43%.
  • FMS has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (3/2/2026, 8:20:36 PM)

After market: 23.47 0 (0%)

23.47

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners43.91%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.77B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (15.89%)
Short Float %0.57%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 3.65%
Yearly Dividend0.85
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.86%
Min EPS beat(2)-31.87%
Max EPS beat(2)14.16%
EPS beat(4)3
Avg EPS beat(4)6.09%
Min EPS beat(4)-31.87%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)13.15%
EPS beat(12)9
Avg EPS beat(12)10.43%
EPS beat(16)11
Avg EPS beat(16)8.72%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)2.39%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.28%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.35%
PT rev (1m)-2.48%
PT rev (3m)-2.87%
EPS NQ rev (1m)12.25%
EPS NQ rev (3m)14.55%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 11.5
Fwd PE 9.84
P/S 0.59
P/FCF 6.69
P/OCF 4.35
P/B 0.88
P/tB N/A
EV/EBITDA 6.11
EPS(TTM)2.04
EY8.69%
EPS(NY)2.38
Fwd EY10.16%
FCF(TTM)3.51
FCFY14.95%
OCF(TTM)5.39
OCFY22.98%
SpS39.48
BVpS26.77
TBVpS-3.05
PEG (NY)0.69
PEG (5Y)N/A
Graham Number35.06
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.83
F-Score8
WACC5.25%
ROIC/WACC1.01
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-1.52%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year76.05%
EBIT Next 3Y25.14%
EBIT Next 5Y17.47%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


What is the profitability of FMS stock?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 16.67% in the next year.


Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?

The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 43.19%.